Sep. 4 at 4:19 PM
$RIGL https://www.benzinga.com/news/26/09/61631407/evp-chief-financial-officer-rigel-pharmaceuticals-exercises-options-worth-123k?mod=mw_quote_news
Rigel CFO Dean Schorno exercised options for 4,600 shares at prices between
$12.70 and
$24.20, spending approximately
$99,929. He did not sell the newly acquired shares, while 928 shares were withheld to cover taxes or exercise costs. This is slightly positive because his total ownership increased to 82,962 shares, but it was not an open-market purchase.
